Live Vital Review 2026
Reviewed August 7, 2026 · Compounded peptide blends only — GHK-Cu, BPC-157, TB-500 and KPV. Not FDA-approved. No GLP-1 medication offered.
Visit Live Vital WebsiteOverview
Live Vital sells compounded peptide protocols for skin quality, recovery and longevity, and the first thing to say for readers of this site is that it offers no GLP-1 and no weight-loss medication at all. If tirzepatide is what you are looking for, this is the wrong provider entirely. Reviewed on its own terms, it does two things well. It names its physician — Dr Patrick Taylor, MD — and states that every protocol is prescribed after a medical intake 'by a doctor you can actually talk to', with a free consultation offered first. And it publishes clear per-protocol pricing, from $99/month for a GHK-Cu copper peptide up to $149/month for its multi-peptide blends, with an explanation of the intended mechanism rather than a bare benefit claim. Those are better habits than most peptide vendors display. The problem is what is actually in the products. Live Vital's blends are built around BPC-157 and TB-500. In September 2023 the FDA placed BPC-157 in Category 2 of its interim 503A bulk drug substances list — the category for substances that raise significant safety concerns and which the agency stated compounders would not be permitted to use — citing immunogenicity risk for certain routes of administration and difficulty characterising peptide-related impurities. Thymosin beta-4 fragments including TB-500 have faced comparable scrutiny. The regulatory position on compounded peptides has been unsettled through 2026, with the FDA removing a number of peptides from Category 2 in April 2026, so we are not asserting the current legal status — but a prospective buyer should establish it rather than assume it, and should note that these substances are being sold as multi-peptide compounded blends whose combined safety has never been studied.
Medications Offered
Brand-name or compounded: Compounded peptide blends only — GHK-Cu, BPC-157, TB-500 and KPV. Not FDA-approved. No GLP-1 medication offered.
- GHK-Cu copper peptide — $99/month, marketed for collagen, texture and elasticity
- 'Glow' — compounded GHK-Cu / BPC-157 / TB-500 blend, $149/month
- 'Klow' — compounded GHK-Cu / KPV / BPC-157 / TB-500 blend, $149/month
- 'Wolverine' — compounded BPC-157 / TB-500 recovery blend
- Additional protocols observed at $66, $83, $116 and $166 per month
- No GLP-1, semaglutide or tirzepatide of any kind
Consultation Process
Free consultation
Live Vital offers a free consultation before any intake, so establishing whether a protocol is appropriate costs nothing.
Medical intake
Every protocol is stated to be prescribed after a medical intake by Dr Patrick Taylor, MD. Raise the BPC-157 and TB-500 regulatory question explicitly at this stage.
Compounded blend prepared
Protocols are compounded blends rather than single agents. No pharmacy is named and no 503A or 503B status is stated.
Ongoing protocol
Protocols are billed monthly. No cancellation process, refund policy or monitoring cadence is published.
Eligibility
- Adults; no published age range or clinical criteria
- Medical intake and physician prescription required
- State availability is not published
- Not applicable as a weight-loss service — no GLP-1 offered
- Anyone with a history of malignancy should discuss tissue-repair peptides with an independent clinician before use
Provider Involvement
Better than most peptide vendors on the surface. Dr Patrick Taylor, MD is named as the Live Vital physician, every protocol is stated to follow a medical intake, and a free consultation is offered up front — a materially more accountable structure than the anonymous vendors that dominate this category. What is missing is any published monitoring protocol, lab requirement or follow-up cadence for products whose safety profile the FDA has actively questioned.
Lab Requirements
None published. Given the regulatory concerns attached to these substances, ask what monitoring applies.
Pharmacy Fulfillment
Not named. Live Vital sells compounded blends but does not identify the compounding pharmacy or state its 503A or 503B status. That is a material omission here specifically, because the permissibility of compounding BPC-157 and related peptides has been the subject of direct FDA action.
Shipping Frequency
Not published.
Membership Fees vs. Medication Fees
Membership fees
None advertised. Pricing is per protocol per month.
Medication fees
- GHK-Cu: $99/month
- 'Glow' (GHK-Cu / BPC-157 / TB-500): $149/month
- 'Klow' (GHK-Cu / KPV / BPC-157 / TB-500): $149/month
- Other protocols observed at $66, $83, $116 and $166/month
- Consultation: free
Cancellation & Refund Policy
Cancellation
Not published. Establish before providing payment details.
Refunds
Not published on the pages we reviewed.
Insurance
Not offered. Compounded peptide protocols are cash-pay and not reimbursable.
HSA / FSA
Not stated.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Free consultation before intake
- Named physician
- Published mechanism explanations for each protocol
- Goal-organised catalogue
State Availability
Not published.
Pros
- Names its physician — Dr Patrick Taylor, MD — and offers a free consultation
- States every protocol is prescribed after a medical intake by a doctor you can talk to
- Publishes clear per-protocol pricing from $66 to $166 per month
- Explains the mechanism behind each protocol rather than making bare benefit claims
- Organised by goal, so you can see what each blend is intended to address
Cons
- The catalogue is built on BPC-157 and TB-500, peptides the FDA placed in Category 2 of the interim 503A bulks list over safety concerns
- No GLP-1 or weight-loss medication of any kind — irrelevant if you want tirzepatide
- Multi-peptide compounded blends have no established safety or efficacy data as combinations
- Branding such as 'Wolverine' frames prescription peptides as consumer products
- No published cancellation policy, refund terms, state list or lab requirements
- No independent review record found
Who Live Vital May Be Best For
- We would not recommend these products. Anyone considering them should first discuss the FDA's position on BPC-157 and TB-500 with an independent clinician who is not selling them.
Limitations
- Built on peptides the FDA placed in Category 2 of the 503A bulks list
- Multi-peptide blends with no combined safety or efficacy data
- No GLP-1 or weight-loss treatment whatsoever
- No pharmacy named, no monitoring, no cancellation or refund terms
Reputation & Trust
This is a case where the presentation is better than the product. Live Vital names its physician, offers a free consultation, requires a medical intake, publishes clear per-protocol prices and explains the intended mechanism of each blend rather than making bare claims — all habits that distinguish it from the anonymous peptide sellers this category is full of. But the catalogue itself rests on substances the FDA has specifically flagged. BPC-157 was placed in Category 2 of the interim 503A bulks list in September 2023, meaning the agency considered it to raise significant safety concerns and stated compounders would not be permitted to use it, citing immunogenicity risk and difficulty characterising peptide impurities; thymosin beta-4 fragments such as TB-500 have drawn comparable scrutiny. The position shifted during 2026, with certain peptides removed from Category 2 in April, so the current legal status is genuinely unsettled and we are not asserting it. What is not unsettled is the evidence question: these are multi-peptide compounded blends whose combined safety and effectiveness have never been studied in humans, sold under consumer-product names like 'Wolverine' and 'Glow'. A named doctor and a free consultation do not substitute for that missing evidence.
What Makes Live Vital Different
- Named physician and free consultation before intake
- Clear per-protocol monthly pricing
- Mechanism explanations rather than bare benefit claims
Our Verdict
Live Vital earns 2.5/5. It presents itself considerably better than most peptide sellers: it names its physician, Dr Patrick Taylor, MD, requires a medical intake before prescribing, offers a free consultation, publishes clear per-protocol pricing from $66 to $166 a month, and explains the intended mechanism of each blend rather than making bare claims. Those are real distinctions in a category full of anonymous vendors. But the catalogue is built on BPC-157 and TB-500 — and BPC-157 is a substance the FDA placed in Category 2 of its interim 503A bulks list in September 2023, stating it raises significant safety concerns and that compounders would not be permitted to use it, citing immunogenicity risk and impurity characterisation problems. The 2026 position has been in flux and we are not asserting the current legal status, but a buyer should establish it rather than assume. Beyond legality there is the evidence question: these are multi-peptide compounded blends whose combined safety has never been studied in humans, sold under names like 'Wolverine' and 'Glow'. A named prescriber does not manufacture missing data. And for readers of this site, the simpler point applies first: there is no GLP-1 here at all.
Alternatives to Live Vital
If peptides are the goal, a platform that names its medical board and publishes its third-party testing parameters.
Longevity and hormone care anchored to 50+ biomarker testing rather than compounded blends.
Peptides alongside real lab testing and published clinical research.
If a GLP-1 is what you actually want, published compounded pricing from $86/month.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
Does Live Vital offer GLP-1s or weight-loss medication?
No. Live Vital sells compounded peptide protocols for skin, recovery and longevity only. There is no semaglutide, tirzepatide or any other weight-loss medication on the platform. If that is what you need, use a dedicated weight-management provider.
Is BPC-157 legal to buy from a compounding pharmacy?
The position is unsettled and worth checking before you buy. In September 2023 the FDA placed BPC-157 in Category 2 of its interim 503A bulk drug substances list — substances raising significant safety concerns that the agency said compounders would not be permitted to use — citing immunogenicity risk for certain routes and difficulty characterising peptide impurities. In April 2026 the FDA removed a number of peptides from Category 2 and the wider policy has been in flux. Ask Live Vital directly what the current status is, which pharmacy compounds the product, and discuss it with an independent clinician.
Are multi-peptide blends safer or more effective than single peptides?
There is no evidence either way, which is the point. Blends such as 'Glow' (GHK-Cu / BPC-157 / TB-500) and 'Klow' (adding KPV) combine several compounded substances that have not been studied together in humans. Combining agents multiplies the unknowns rather than reducing them, and none of these products is FDA-approved for any indication.
Is a named doctor enough reassurance?
It is better than nothing and genuinely better than most peptide vendors offer — Dr Patrick Taylor, MD is named, a medical intake is required and a free consultation is offered. But a prescriber's involvement does not generate safety data that does not exist. The questions to ask are about the substances themselves, not about who is signing for them.
Important Notes & Warnings
- This review is informational only and is not medical advice. Consult an independent licensed clinician — not the seller — before using any of these products.
- Live Vital offers NO GLP-1 or weight-loss medication.
- BPC-157 was placed by the FDA in Category 2 of its interim 503A bulks list in September 2023, citing significant safety concerns including immunogenicity risk and impurity characterisation difficulties. TB-500 and related thymosin beta-4 fragments have faced comparable scrutiny. The 2026 position is unsettled — confirm the current status before purchasing.
- Multi-peptide compounded blends have no established safety or efficacy data as combinations.
- Compounded peptide products are NOT FDA-approved and have not been evaluated for safety, effectiveness or quality.
- Tissue-repair peptides warrant particular caution in anyone with a personal history of malignancy — discuss with an independent clinician.
- No compounding pharmacy is named, and no monitoring, cancellation or refund terms are published.
Sources
- Live Vital treatment and protocol pages, livevital.io (accessed 7 August 2026)
- FDA, 'Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks' — BPC-157 placed in Category 2 of the interim 503A bulks list, September 2023
- Reporting on the FDA's April 2026 removal of certain peptides from Category 2 of the interim 503A bulks list
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 7, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.